Zheng Y, van den Kerkhof M, Ibrahim M, de Esch I, Maes L, Sterk G
J Med Chem. 2024; 67(4):2849-2863.
PMID: 38330051
PMC: 10895668.
DOI: 10.1021/acs.jmedchem.3c01976.
Marchetti F, Tombesi A, Di Nicola C, Pettinari R, Verdicchio F, Crispini A
Inorg Chem. 2022; 61(34):13561-13575.
PMID: 35969809
PMC: 9446893.
DOI: 10.1021/acs.inorgchem.2c02201.
Lutje V, Probyn K, Seixas J, Bergman H, Villanueva G
Cochrane Database Syst Rev. 2021; 12:CD015374.
PMID: 34882307
PMC: 8656462.
DOI: 10.1002/14651858.CD015374.
Llurba Montesino N, Kaiser M, Maser P, Schmidt T
Molecules. 2021; 26(11).
PMID: 34072147
PMC: 8199030.
DOI: 10.3390/molecules26113226.
Davis C, Rock K, Antillon M, Mwamba Miaka E, Keeling M
BMC Med. 2021; 19(1):86.
PMID: 33794881
PMC: 8017623.
DOI: 10.1186/s12916-021-01943-4.
The Alkaloid-Enriched Fraction of (Buxaceae) Shows Prominent Activity against .
Flittner D, Kaiser M, Maser P, Lopes N, Schmidt T
Molecules. 2021; 26(3).
PMID: 33498621
PMC: 7865568.
DOI: 10.3390/molecules26030591.
Assembling Pharma Resources to Tackle Diseases of Underserved Populations.
Kempf D, Marsh K
ACS Med Chem Lett. 2020; 11(6):1094-1100.
PMID: 32550987
PMC: 7294558.
DOI: 10.1021/acsmedchemlett.0c00051.
Innovative Partnerships for the Elimination of Human African Trypanosomiasis and the Development of Fexinidazole.
Neau P, Hanel H, Lameyre V, Strub-Wourgaft N, Kuykens L
Trop Med Infect Dis. 2020; 5(1).
PMID: 32012658
PMC: 7157581.
DOI: 10.3390/tropicalmed5010017.
The Drugs of Sleeping Sickness: Their Mechanisms of Action and Resistance, and a Brief History.
de Koning H
Trop Med Infect Dis. 2020; 5(1).
PMID: 31963784
PMC: 7157662.
DOI: 10.3390/tropicalmed5010014.
Assessing the impact of aggregating disease stage data in model predictions of human African trypanosomiasis transmission and control activities in Bandundu province (DRC).
Castano M, Ndeffo-Mbah M, Rock K, Palmer C, Knock E, Mwamba Miaka E
PLoS Negl Trop Dis. 2020; 14(1):e0007976.
PMID: 31961872
PMC: 6994134.
DOI: 10.1371/journal.pntd.0007976.
Tsetse peritrophic matrix influences for trypanosome transmission.
Aksoy S
J Insect Physiol. 2019; 118:103919.
PMID: 31425686
PMC: 6853167.
DOI: 10.1016/j.jinsphys.2019.103919.
Scaffold hybridization strategy towards potent hydroxamate-based inhibitors of viruses and species.
Giannakopoulou E, Pardali V, Frakolaki E, Siozos V, Myrianthopoulos V, Mikros E
Medchemcomm. 2019; 10(6):991-1006.
PMID: 31303998
PMC: 6596085.
DOI: 10.1039/c9md00200f.
The European Medicines Agency's scientific opinion on oral fexinidazole for human African trypanosomiasis.
Pelfrene E, Harvey Allchurch M, Ntamabyaliro N, Nambasa V, Ventura F, Nagercoil N
PLoS Negl Trop Dis. 2019; 13(6):e0007381.
PMID: 31246956
PMC: 6597029.
DOI: 10.1371/journal.pntd.0007381.
Nongenotoxic 3-Nitroimidazo[1,2-]pyridines Are NTR1 Substrates That Display Potent Antileishmanial Activity.
Fersing C, Basmaciyan L, Boudot C, Pedron J, Hutter S, Cohen A
ACS Med Chem Lett. 2019; 10(1):34-39.
PMID: 30655943
PMC: 6331159.
DOI: 10.1021/acsmedchemlett.8b00347.
Improvement of Aqueous Solubility of Lapatinib-Derived Analogues: Identification of a Quinolinimine Lead for Human African Trypanosomiasis Drug Development.
Bachovchin K, Sharma A, Bag S, Klug D, Schneider K, Singh B
J Med Chem. 2018; 62(2):665-687.
PMID: 30565932
PMC: 6556231.
DOI: 10.1021/acs.jmedchem.8b01365.
FRET Flow Cytometry-Based High Throughput Screening Assay To Identify Disrupters of Glucose Levels in Trypanosoma brucei.
Voyton C, Morris M, Ackroyd P, Morris J, Christensen K
ACS Infect Dis. 2018; 4(7):1058-1066.
PMID: 29741365
PMC: 6350775.
DOI: 10.1021/acsinfecdis.8b00058.
